BioNTech collaborates with AGC BiologicsAGC Biologics supports BioNTech’s manufacturing of an Omicron-based vaccine with plasmids for in vitro transcription. more ➔
EU Council confirms European Scale-up Init...EU Members States agreed on Tuesday to launch the pan-European Scale-up Initiative, which is aimed to provide €10bn for late-state tech companies. more ➔
Protix raises €50m for expansionDutch insect protein specialist Protix has raised €50m for expansion and development from international investors and the ECBF. more ➔
Viennese Ribbon Biolabs closes €18m Seri...Ribbon Biolabs has cashed in €18m in Series A financing led by Hadean Ventures more ➔
mRNA specalist Ethris raises $26m in Serie...German mRNA and LNP specialist Ethris GmbH has closed a $26m Series B round led by Laureus Capital. more ➔
Evotec and Boehringer Ingelheim enter drug... Evotec SE will use its PanOmics platform to validate and screen targets and drug candidates in ophtalmology for Boehringer Ingelheim. more ➔
BioNTech and Pfizer evaluate Omicron-speci...Pfizer Inc and BioNTech SE have started clinical safety testing of an Omikron-specific vaccine in healthy adults 18 through 55 years of age. more ➔
Cytovation AS kicks-off with $20m Series A...Norway’s immuno-oncology specialist Cytovation A/S has raised $20m in a Series A financing led by early-stage investor Sandwater. more ➔
Valneva vaccine neutralises Omicron varian...French-Austrian vaccine specialist Valneva SE has demonstrated that its COVID-19 vaccine induced neutralisation of 87% of the Omicron variant. more ➔
Neurimmune expands drug discovery collabor...Swiss Neurimmune AG has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. covering antibody drug targeting neurodegenerative diseases more ➔
